Skip to main content
. 2020 Sep 11;48(5):1859–1875. doi: 10.1042/BST20190338

Figure 2. Canonical Activation of ERK5 and Paradoxical Activation of ERK5, PKB and RAF by kinase inhibitors.

Figure 2.

TAD, transactivation domain; NLS, nuclear localisation signal; PH, pleckstrin homology domain; RBD, RAS binding domain. Figure created using bioRENDER.com.